ScoreWhy is Shandong Jincheng Pharmaceutical Group Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -1.15% and Operating profit at -19.54% over the last 5 years
2
Flat results in Mar 26
- NET PROFIT(9M) At CNY 58.67 MM has Grown at -42.22%
- ROCE(HY) Lowest at 1.79%
- DEBTORS TURNOVER RATIO(HY) Lowest at 3.85 times
3
With ROE of 1.75%, it has a expensive valuation with a 1.19 Price to Book Value
- Over the past year, while the stock has generated a return of -21.46%, its profits have fallen by -57.9%
- At the current price, the company has a high dividend yield of 2
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -21.46% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Shandong Jincheng Pharmaceutical Group Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Shandong Jincheng Pharmaceutical Group Co., Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Shandong Jincheng Pharmaceutical Group Co., Ltd.
-29.22%
-0.41
36.14%
China Shanghai Composite
3.23%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-1.15%
EBIT Growth (5y)
-19.54%
EBIT to Interest (avg)
10.02
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.04
Sales to Capital Employed (avg)
0.73
Tax Ratio
37.47%
Dividend Payout Ratio
214.59%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.03%
ROE (avg)
5.55%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
71
Industry P/E
Price to Book Value
1.24
EV to EBIT
46.28
EV to EBITDA
12.38
EV to Capital Employed
1.27
EV to Sales
1.50
PEG Ratio
NA
Dividend Yield
1.96%
ROCE (Latest)
2.75%
ROE (Latest)
1.75%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend19What is working for the Company
DEBT-EQUITY RATIO
(HY)
Lowest at -13.81 %
PRE-TAX PROFIT(Q)
Highest at CNY 97.25 MM
NET PROFIT(Q)
Highest at CNY 81.05 MM
EPS(Q)
Highest at CNY 0.21
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Shandong Jincheng Pharmaceutical Group Co., Ltd.
Pre-Tax Profit
At CNY 97.25 MM has Grown at 269.2%
over average net sales of the previous four periods of CNY 26.34 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 81.05 MM has Grown at 383%
over average net sales of the previous four periods of CNY 16.78 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Pre-Tax Profit
Highest at CNY 97.25 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
Highest at CNY 81.05 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
EPS
Highest at CNY 0.21
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Debt-Equity Ratio
Lowest at -13.81 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Shandong Jincheng Pharmaceutical Group Co., Ltd.
Non Operating Income
Highest at CNY 0.77 MM
in the last five periodsMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating income
Footer loading
